Is CPB a Buy or a Sell? The Bull and Bear Case (2026)

Last updated July 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for The Campbell's Company (CPB) rests on Meals & Beverages is doing the load-bearing work: The soup, broth and sauce half generated about ~$762M of segment operating earnings on ~$4.74B of nine-month sales in fiscal 2026, a margin near ~16%, versus roughly ~10% for Snacks. The bear case rests on the largest risk is that volume decline is structural. Analysts covering it publish targets from $14.00 to $56.00 against a $23.47 price, so even the professionals disagree by 191% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

The Campbell's Company renamed itself from Campbell Soup Company in November 2024, and the new name was meant to describe what the business had become. It runs two reportable segments. Meals & Beverages is the larger one at roughly ~$4.74B of sales over the first nine months of fiscal 2026, and it holds Campbell's condensed and ready-to-serve soup, Chunky, Swanson, Pace, Prego, Pacific Foods, V8 and Rao's, the premium Italian sauce brand that arrived with the ~$2.7B Sovos Brands purchase in 2024. Snacks contributed roughly ~$2.87B over the same nine months: Pepperidge Farm, Goldfish, Milano, Snyder's of Hanover, Lance, Cape Cod, Kettle Brand and Late July. Total fiscal 2025 net sales were about ~$10.25B on a 53-week year, and the company employed approximately ~13,700 people as of early August 2025. Mick Beekhuizen is CEO and Carrie Anderson is CFO. The investment picture in August 2026 is a valuation that reflects several quarters of shrinking. Third-quarter fiscal 2026 results, reported on June 8 for the period ended May 3, showed net sales of about ~$2.37B, down ~4% reported and organic, with volume and mix down ~5% against price up ~1%. Adjusted EPS fell ~32% to about ~$0.50, while GAAP EPS rose to ~$0.41 from ~$0.22 because the prior-year quarter carried a ~$150M Snyder's of Hanover trademark impairment. Management reaffirmed full-year guidance of ~2% to ~1% organic sales decline, adjusted EBIT down ~20% to ~17%, and adjusted EPS of ~$2.15 to ~$2.25. At a share price near ~$23 and a market capitalization around ~$7.0B, the stock trades near ~11.5x trailing GAAP earnings of about ~$2.04 per share, yields roughly ~6.7%, and carries net debt of about ~$6.6B. The question being priced is whether this year's tariff and inflation hit to margins unwinds, or whether the volume declines in snacks turn a cyclical earnings dip into a permanently smaller company.

The bull case: what would have to be true for $56.00

The most optimistic published target on CPB is $56.00, +138.6% from the $23.47 price as of August 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Meals & Beverages is doing the load-bearing work

The soup, broth and sauce half generated about ~$762M of segment operating earnings on ~$4.74B of nine-month sales in fiscal 2026, a margin near ~16%, versus roughly ~10% for Snacks. Management credits durable at-home cooking for the shelf position Campbell's, Rao's and Swanson hold even as U.S. soup sales fell ~8% in the third quarter. Rao's is the growth asset inside a shrinking portfolio, and how far it can be extended past pasta sauce is the single largest swing factor in the Meals & Beverages story.

2. Snacks is where the earnings actually went

Snacks operating earnings fell ~32% in the third quarter to about ~$95M and ~26% over nine months, on sales down ~4% with volume and mix off ~6%. The declines run across crackers, pretzels, chips, fresh bakery and contract manufacturing, which suggests a category problem rather than one broken brand. The stated fixes are narrow and specific: focus Goldfish on households with kids, improve execution in Pepperidge Farm fresh bakery, and restructure the salty portfolio, alongside a direct-store-delivery route consolidation costing up to ~$115M through 2029.

3. Cost savings racing tariffs and input inflation

The company has banked about ~$200M of a ~$375M cost savings program targeted for the end of fiscal 2028, adding roughly ~$20M in the third quarter. Those savings are being consumed rather than banked: adjusted gross margin fell about ~240 basis points to ~27.7%, and management put the net tariff impact at approximately ~$0.17 per share in the quarter alone. Whether fiscal 2027 earnings recover depends heavily on whether tariff costs and supply-chain inflation moderate while the remaining ~$175M of savings lands.

4. Portfolio surgery in both directions

Campbell's has been selling slow assets and buying control of fast ones. Pop Secret went in August 2024 and noosa yoghurt in February 2025, both now small headwinds to reported sales. In the other direction, the company closed on ~49% of La Regina on May 4, 2026 for ~$146M in cash out of ~$286M total consideration, taking a direct stake in the Italian supplier that produces all of its Rao's tomato-based sauces, with options that could take it to full ownership at an implied equity value near ~$584M.

The bear case: what would have to be true for $14.00

The most pessimistic published target is $14.00, -40.3% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks The Campbell's Company is worth if the risks below bite instead of the drivers above.

The largest risk is that volume decline is structural. Sales have now fallen roughly ~4% in each of the last three reported quarters with price carrying ~1% to ~2%, which means the company is selling meaningfully fewer units and using price to soften the arithmetic, a lever that eventually meets private-label competition. Debt compounds the problem: about ~$7.0B of total borrowings against roughly ~$4.0B of book equity, itself resting on ~$5.0B of goodwill and ~$4.3B of other intangibles, leaves limited room if brand values are written down again after the ~$176M of trademark impairments taken in fiscal 2025. The dividend near ~$1.56 per share costs roughly ~$465M a year against nine-month operating cash flow of ~$839M and capex of ~$297M, so it is covered today but with less cushion than the yield alone suggests. Separately, the U.S. Department of Justice and private environmental groups filed Clean Water Act lawsuits in March 2024 in the Northern District of Ohio over discharges from the Napoleon, Ohio wastewater facility; the company says it is in settlement discussions and does not expect a material effect, and there is no securities-fraud class action on file.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding CPB already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on CPB

17 analysts cover CPB, with an average target of $22.00 (-6.3% against $23.47) and a split of 1 buy, 13 hold, 6 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the CPB forecast and price target page.

How is CPB valued? (as of August 2026)

Price
$23.47
Market cap
$7.00B
P/E (TTM)
11.85
Forward P/E
12.23
Price / book
1.74
Beta
0.01
52-week range
$19.56 to $34.17

Snapshot for CPB as of August 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Revenue (TTM): ~$9.9B
  • Q3 FY2026 net sales (quarter ended May 3, 2026): ~$2.37B, down ~4% reported and organic
  • FY2026 adjusted EPS guidance: ~$2.15 to ~$2.25, down ~26% to ~23%
  • Trailing P/E: ~11.5x on ~$2.04 GAAP EPS
  • Net debt: ~$6.6B (~$7.0B total debt less ~$402M cash)
  • Nine-month operating cash flow: ~$839M, capex ~$297M

The trailing multiple near ~11.5x sits well below the large-cap packaged-food average, and the forward multiple near ~12.6x is higher precisely because guided fiscal 2026 earnings are lower than the trailing figure. That inversion is the whole valuation argument in one number: the market is paying a discount for a business whose earnings are still falling, so the multiple only looks cheap if fiscal 2026 marks the bottom. The stock has traded between roughly ~$19.56 and ~$34.18 over the past year, and full-year fiscal 2026 results are the next scheduled data point.

How do you decide if CPB is a buy?

Rather than asking whether CPB is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold CPB indirectly through an index or sector ETF before adding more.

What would change your mind on CPB

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Meals & Beverages is doing the load-bearing work stalls in the reported numbers rather than in the narrative around them.
  • Bear case breaks if: the largest risk is that volume decline is structural fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the CPB stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CPB against your real portfolio and see your actual exposure before deciding.

Investing in The Campbell's Company with AI

Connect the broker you already use and ask Walnut's AI how CPB fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is CPB a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Meals & Beverages is doing the load-bearing work, with revenue (ttm) at ~$9.9B. The bear case rests on the largest risk is that volume decline is structural. Analysts covering it are spread from $14.00 to $56.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell CPB?

+

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The largest risk is that volume decline is structural. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $14.00, -40.3% from the $23.47 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for CPB?

+

Meals & Beverages is doing the load-bearing work. The soup, broth and sauce half generated about ~$762M of segment operating earnings on ~$4.74B of nine-month sales in fiscal 2026, a margin near ~16%, versus roughly ~10% for Snacks. The most optimistic analyst target on CPB is $56.00, +138.6% from the $23.47 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for CPB?

+

The largest risk is that volume decline is structural. Sales have now fallen roughly ~4% in each of the last three reported quarters with price carrying ~1% to ~2%, which means the company is selling meaningfully fewer units and using price to soften the arithmetic, a lever that eventually meets private-label competition. Debt compounds the problem: about ~$7.0B of total borrowings against roughly ~$4.0B of book equity, itself resting on ~$5.0B of goodwill and ~$4.3B of other intangibles, leaves limited room if brand values are written down again after the ~$176M of trademark impairments taken in fiscal 2025. The dividend near ~$1.56 per share costs roughly ~$465M a year against nine-month operating cash flow of ~$839M and capex of ~$297M, so it is covered today but with less cushion than the yield alone suggests. Separately, the U.S. Department of Justice and private environmental groups filed Clean Water Act lawsuits in March 2024 in the Northern District of Ohio over discharges from the Napoleon, Ohio wastewater facility; the company says it is in settlement discussions and does not expect a material effect, and there is no securities-fraud class action on file. The most pessimistic published target is $14.00, -40.3% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

What does The Campbell's Company do?

+

Packaged-food maker behind Campbell's soup, Rao's, Prego, Swanson, V8, Goldfish, Pepperidge Farm and Snyder's of Hanover.

What would have to change for CPB to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Meals & Beverages is doing the load-bearing work) stalling in the reported numbers rather than in the narrative, the risk above (the largest risk is that volume decline is structural) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What company is CPB?

+

CPB is the Nasdaq ticker for The Campbell's Company, headquartered in Camden, New Jersey. It was known as Campbell Soup Company until November 2024, when the name changed to reflect a portfolio that is now roughly ~62% meals and beverages and ~38% snacks by sales. It employed about ~13,700 people as of August 2025.

How do you invest in CPB?

+

CPB is an ordinary US-listed common stock, so it can be bought through any brokerage account that supports Nasdaq equities, in whole shares or fractionally at brokers that offer that. Some investors hold it indirectly through consumer-staples index funds or dividend-focused ETFs, where it typically sits as a small weight alongside larger food and beverage names.

Why is CPB stock down?

+

Net sales have declined about ~4% in each of the last three reported quarters, driven by volume and mix rather than price, and adjusted EPS fell ~32% in the third quarter of fiscal 2026. Management guided full-year fiscal 2026 adjusted EPS to ~$2.15 to ~$2.25 against ~$2.91 in fiscal 2025 on a comparable 52-week basis, with tariffs alone costing roughly ~$0.17 per share in the third quarter.

Walnut is informational, not investment advice, and gives no verdict on CPB. Analyst targets referenced here come from a August 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

Related stocks

    Is CPB a Buy or a Sell? The Bull and Bear Case (2026) - Walnut AI Investing App